Cargando…
Single-dose of a replication-competent adenovirus-vectored vaccine provides sterilizing protection against Rift Valley fever virus challenge
Rift Valley fever virus (RVFV) is one of the most important virulent pathogens causing severe disease in animals and humans. However, there is currently no approved vaccine to prevent RVFV infection in humans. The use of human adenovirus serotype 4 (Ad4) as a vector for an RVFV vaccine has not been...
Autores principales: | Bian, Ting, Wang, Busen, Fu, Guangcheng, Hao, Meng, Chen, Yi, Fang, Ting, Liu, Shuling, Yu, Changming, Li, Jianmin, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691644/ https://www.ncbi.nlm.nih.gov/pubmed/36439179 http://dx.doi.org/10.3389/fimmu.2022.907675 |
Ejemplares similares
-
A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
por: Bian, Ting, et al.
Publicado: (2023) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013) -
An adenovirus-vectored RVF vaccine confers complete protection against lethal RVFV challenge in A129 mice
por: Hao, Meng, et al.
Publicado: (2023) -
Author Correction: A Rift Valley fever mRNA vaccine elicits strong immune responses in mice and rhesus macaques
por: Bian, Ting, et al.
Publicado: (2023) -
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
por: Warimwe, George M., et al.
Publicado: (2016)